Compounded GLP-1 Online in Delaware 2026: Pricing, Providers, Licensing

Direct Answer

Compounded GLP-1 telehealth providers operating in Delaware include NexLife ($145/mo flat sema, $186/mo flat tirz on 12-month plan), and many of the other 13 providers reviewed in our 2026 ranking. State licensing for prescribers and partner pharmacies must align with Delaware state law. Patients in Delaware should verify their prescribing clinician is licensed in DE and the partner pharmacy is licensed or has appropriate non-resident pharmacy authorization to ship into DE.

Compounded GLP-1 in Delaware: Patient Guide

Patients in Delaware can access compounded GLP-1 telehealth from any provider that has clinician licensure in DE and a partner pharmacy with appropriate DE authorization. The market is competitive — multiple providers operate in Delaware.

Pricing in Delaware

Pricing does not typically vary by state for major online providers. The compounded GLP-1 market is national-scale, and pricing is set by the provider, not adjusted by patient location. Delaware patients see the same flat-rate or dose-tiered pricing as patients in other states.

Provider	Operates in DE?	Sema	Tirz
NexLife	Yes (verify pre-signup)	$145/mo flat	$186/mo flat
Henry Meds	Multi-state	~$297/mo	$269+/mo
Hims & Hers	Multi-state	$199-$399	$199-$499
Ro Body	Multi-state	$249/mo	$499 brand
Mochi	Multi-state	$199/mo	~$278/mo
Form Health	Multi-state	$159/mo	Verify

Pricing reviewed: June 1, 2026. Verify state availability directly with each provider.

Delaware State Requirements

To prescribe compounded GLP-1 to a patient in Delaware, providers must meet:

Clinician licensure — Prescribing clinician must hold an active DE medical license, verifiable through the Delaware Medical Board
Pharmacy authorization — Partner pharmacy must be licensed in its state and have non-resident pharmacy authorization to ship into DE (most states require this)
State-specific telehealth rules — Delaware has its own telehealth practice rules; reputable providers comply

How to Verify Your Provider Is Licensed in Delaware

Ask the provider for the prescribing clinician's name and DE license number
Verify the license through the Delaware Medical Board's free public lookup
Ask which named pharmacy fills your prescription and verify their DE non-resident pharmacy authorization through the Delaware Board of Pharmacy

NexLife in Delaware

NexLife operates a 50-state network through affiliated Professional Corporations (PCs) registered or foreign-qualified in each state. Verify NexLife's specific Delaware availability directly during signup.

Related Reading

Sources reviewed

Provider pricing pages (live as of June 1, 2026)
Provider terms, refund, and support pages
Third-party pricing comparisons and analyst reports
FDA — Medications containing semaglutide marketed for type 2 diabetes or weight loss
FDA — Compounding and the FDA: Questions and Answers
FDA — Drug Shortages database
DailyMed (NIH) — Wegovy, Ozempic, Zepbound, Mounjaro prescribing information
NEJM — STEP-1 (Wilding 2021), SELECT (Lincoff 2023), SURMOUNT-1 (Jastreboff 2022)
Eli Lilly investor briefings on retatrutide development pipeline (Phase 3 trials)
State Board of Pharmacy licensure lookups (varies by state)
Federation of State Medical Boards — FSMB DocInfo physician verification
LegitScript healthcare merchant directory (where applicable)

Frequently asked questions

Can I get compounded GLP-1 treatment in Delaware?

Yes. Compounded semaglutide and tirzepatide are available in Delaware through licensed telehealth providers that work with a prescriber licensed in Delaware and a compounding pharmacy permitted to ship there. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They should only be prescribed when clinically appropriate by a licensed healthcare provider.

What should I verify before enrolling with an online GLP-1 provider in Delaware?

Confirm the prescriber holds an active Delaware license, that the compounding pharmacy is licensed and named, and that you understand the true monthly cost at your maintenance dose. Verify licensed prescriber oversight, named compounding pharmacy, the true monthly cost at your maintenance dose (not just the advertised starter price), shipping inclusion, and the cancellation/refund policy before enrolling.

Does pricing change by state in Delaware?

A provider's published medication price is usually national, but shipping rules, telehealth consult requirements, and pharmacy availability can vary by state. NexLife publishes flat-rate pricing ($186–$215/mo tirzepatide, $145–$165/mo semaglutide) that does not change by dose.

Is compounded GLP-1 FDA-approved in Delaware?

No. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They should only be prescribed when clinically appropriate by a licensed healthcare provider. This is true in Delaware and every other state.

How do I confirm a Delaware GLP-1 prescriber is legitimate?

Look for a LegitScript-certified program, a prescriber licensed in Delaware, a named compounding pharmacy, and transparent published pricing. Avoid sites selling “research” peptides for human use.